JPS57123181A - Preparation of pyrazolo (1,5-a) pyridine derivative - Google Patents
Preparation of pyrazolo (1,5-a) pyridine derivativeInfo
- Publication number
- JPS57123181A JPS57123181A JP56008812A JP881281A JPS57123181A JP S57123181 A JPS57123181 A JP S57123181A JP 56008812 A JP56008812 A JP 56008812A JP 881281 A JP881281 A JP 881281A JP S57123181 A JPS57123181 A JP S57123181A
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pyridine derivative
- carboalkoxypyrazolo
- catalyst
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
PURPOSE: To obtain the titled compound useful as a raw material for a phptosensitive dye, etc. contained in photographic sensitive materials, etc. in high yield, by hydrolyzing a 3-carboalkoxypyrazolo [1,5-a]pyridine derivative, and decarboxylating the hyduolysis product.
CONSTITUTION: A 3-carboalkoxypyrazolo [1,5-a] pyridine derivative expressed by formulaI(R1, R2, R3and R4 are H, alkyl, aryl, etc.; R5 is H, alkyl, etc.; R6 is alkyl, aralkyl, etc.) is hydrolyzed with an alkali, and decarboxylated in the presence of a catalyst, preferably copper oxide, to give a 2-substituted pyrazolo [1,5-a] pyridine derviative expressed by formula II. The hydrolysis is carried out in a solvent, e.g. a lower alcohol or THF, with a base, e.g. a caustic alkali, e.g. KOH, at a reaction temperature of optimally 50W60°C. The decarboxylation reaction is carried out in the presence of cuprous oxide as a catalyst in an amount of 5W10wt% based on the carboxylic acid and at 150W250°C in the absence of the solvent.
COPYRIGHT: (C)1982,JPO&Japio
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56008812A JPS57123181A (en) | 1981-01-23 | 1981-01-23 | Preparation of pyrazolo (1,5-a) pyridine derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56008812A JPS57123181A (en) | 1981-01-23 | 1981-01-23 | Preparation of pyrazolo (1,5-a) pyridine derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS57123181A true JPS57123181A (en) | 1982-07-31 |
JPH0378395B2 JPH0378395B2 (en) | 1991-12-13 |
Family
ID=11703229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56008812A Granted JPS57123181A (en) | 1981-01-23 | 1981-01-23 | Preparation of pyrazolo (1,5-a) pyridine derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57123181A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010030538A3 (en) * | 2008-09-11 | 2010-05-06 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis c |
US7994171B2 (en) | 2008-09-11 | 2011-08-09 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US8048887B2 (en) | 2008-09-11 | 2011-11-01 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US8293909B2 (en) | 2008-09-11 | 2012-10-23 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US8324212B2 (en) | 2010-02-25 | 2012-12-04 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US8354410B2 (en) | 2010-03-11 | 2013-01-15 | Bristol-Meyers Squibb Company | Compounds for the treatment of hepatitis C |
US8445497B2 (en) | 2010-06-30 | 2013-05-21 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US8507722B2 (en) | 2002-05-20 | 2013-08-13 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US9303020B2 (en) | 2012-02-08 | 2016-04-05 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4955615A (en) * | 1972-08-07 | 1974-05-30 |
-
1981
- 1981-01-23 JP JP56008812A patent/JPS57123181A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4955615A (en) * | 1972-08-07 | 1974-05-30 |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8507722B2 (en) | 2002-05-20 | 2013-08-13 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US8293909B2 (en) | 2008-09-11 | 2012-10-23 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US7994171B2 (en) | 2008-09-11 | 2011-08-09 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
JP2012502099A (en) * | 2008-09-11 | 2012-01-26 | ブリストル−マイヤーズ スクイブ カンパニー | Compounds for the treatment of hepatitis C |
US8148382B2 (en) | 2008-09-11 | 2012-04-03 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US8198449B2 (en) | 2008-09-11 | 2012-06-12 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
WO2010030538A3 (en) * | 2008-09-11 | 2010-05-06 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis c |
US8309558B2 (en) | 2008-09-11 | 2012-11-13 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US8722688B2 (en) | 2008-09-11 | 2014-05-13 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US8536338B2 (en) | 2008-09-11 | 2013-09-17 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US8048887B2 (en) | 2008-09-11 | 2011-11-01 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US8324212B2 (en) | 2010-02-25 | 2012-12-04 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US8354410B2 (en) | 2010-03-11 | 2013-01-15 | Bristol-Meyers Squibb Company | Compounds for the treatment of hepatitis C |
US8445497B2 (en) | 2010-06-30 | 2013-05-21 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
US9303020B2 (en) | 2012-02-08 | 2016-04-05 | Bristol-Myers Squibb Company | Compounds for the treatment of hepatitis C |
Also Published As
Publication number | Publication date |
---|---|
JPH0378395B2 (en) | 1991-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS57123181A (en) | Preparation of pyrazolo (1,5-a) pyridine derivative | |
JPS57158769A (en) | Preparation of 2-substituted hydroxyimino-2-(5-amino-1,2,4- thiadiazol-3-yl)acetic acid or its salt, and their intermediate | |
JPS57126427A (en) | Preparation of 1-substituted-azulene derivative | |
JPS5566550A (en) | Preparation of o-(2,6-dichloroanilino)-phenylacetic acid | |
JPS5711981A (en) | Theobromine derivative and its preparation | |
JPS54122220A (en) | Preparation of high purity isoprenyl acetic acid | |
JPS5536431A (en) | Preparation of farnesylacetic acid | |
JPS5566551A (en) | Preparation of o-(2,6-dichloroanilino)-phenylacetic acid | |
JPS5576881A (en) | Preparation of high-purity coproporphyrin 3 alkali salt | |
JPS57203030A (en) | Preparation of hydroxyphenyl-substituted fatty acid | |
JPS5573654A (en) | Preparation of unsaturated ketone compound | |
JPS5492915A (en) | Preparation of beta-hydroxyamino acid | |
JPS5610135A (en) | Preparation of di-n-propylmalonic acid | |
JPS57154164A (en) | Preparation of dl-cysteine or cystine | |
JPS57102875A (en) | 5-acylamino-4-methyloxazole and its preparation | |
JPS5780367A (en) | Preparation of tryptophan and its derivative | |
JPS5531029A (en) | Preparation of 4-substituted amido-3-arylamino-5- pyrazolones | |
JPS572268A (en) | Preparation of 5- p-chlorobenzoyl -1,4-dimethylpyrrole- 2-acetic acid | |
JPS55157579A (en) | Preparation of raw material for polycondensation | |
JPS55102537A (en) | Preparation of 4-hydroxymandelic acid | |
JPS5492989A (en) | Preparation of substituted theobromine | |
JPS5536436A (en) | Production of pyrido 2,3-d pyrimidinecarboxylic acid derivative | |
JPS5543004A (en) | Preparation of alpha-thio-gammadelta-unsaturated carbonyl compound | |
JPS5732254A (en) | Novel preparation of (s)-(-)-1-alkylamino-3-aryl- oxypropane-2-ol | |
JPS5524117A (en) | Preparation of 2-(3-benzoylphenyl) propionic acid |